Article Information
History
- December 20, 2018.
Article Versions
- Version 1 (December 19, 2018 - 16:48).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Sarah E Morgan1,1,
- Jakob Seidlitz1,2,
- Kirstie Whitaker1,3,
- Rafael Romero-Garcia1,
- Nicholas E Clifton4,5,
- Cristina Scarpazza6,7,
- Therese van Amelsvoort8,
- Machteld Marcelis8,
- Jim van Os8,
- Gary Donohoe9,
- David Mothersill9,
- Aiden Corvin10,
- Andrew Pocklington5,
- Armin Raznahan2,
- Philip McGuire6,
- The PSYSCAN Consortium1,
- Petra E Vértes*,1 and
- Edward T Bullmore*,1,11
- 1Department of Psychiatry, University of Cambridge, Cambridge CB2 0SZ, UK
- 2Developmental Neurogenomics Unit, National Institute of Mental Health, Bethesda, MD 20892, USA
- 3The Alan Turing Institute, London, NW1 2DB, UK
- 4Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, UK
- 5MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK
- 6Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London SE5 8AF, UK
- 7Department of General Psychology, University of Padova, 35131 Padova, Italy
- 8Maastricht University, Maastricht, The Netherlands, 616 6200 MD
- 9School of Psychology, NUI Galway, Galway, Ireland, H91 TK33
- 10Department of Psychiatry, Trinity College Dublin, Dublin 8, Ireland
- 11ImmunoPsychiatry, Immuno-Inflammation Therapeutic Area Unit, GlaxoSmithKline R&D, Stevenage SG1 2NY, UK
- ↵1Correspondence: sem91{at}cam.ac.uk
↵* PEV and ETB contributed equally to the work